Skip to content
lifestyle.fairytaleinkbooks.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
AlzeCure Pharma
Final Outcome of AlzeCure’s Rights Issue
July 2, 2026
AlzeCure Pharma Enters an Out-Licensing and Collaboration Agreement with QuantumCell ApS for the NeuroRestore ACD856 Project
July 1, 2026
Communique from the Annual General Meeting of AlzeCure Pharma on 29 June 2026
June 29, 2026
Positive Results From The Phase Ib Clinical Study of NeuroRestore ACD856, Under Development for Alzheimer’s
June 16, 2026
AlzeCure Pharma to Host Live Seminar on The Pain Project TrkA-NAM ACD137 with a Focus on Osteoarthritis and Neuropathic Pain
May 19, 2026
AlzeCure Pharma to Present at Redeye Investor Forum Online on May 21
May 13, 2026
AlzeCure Pharma to Present at ABG Investor Days on May 21
May 13, 2026
New scientific Article Published on TrkA-NAM ACD137 Against Osteoarthritic Pain
May 6, 2026
AlzeCure Publishes its Interim Report for January – March 2026
May 5, 2026
Adjusted Timeline for the Previously Communicated Rights Issue
April 30, 2026
1
2
3
Next Page
→